Newsletter | August 10, 2022

08.10.22 -- Find Biologics CDMOs Ready For Your Projects

 
     
 
 
 
 
Rising To Meet Increasing Demand For Microbial Based Biologics
 

The production of your biotherapeutic deserves the reliability and peace of mind that only a trusted and experienced microbial fermentation partner can provide. Ajinomoto Bio-Pharma Services is a recognized leader in recombinant protein, plasmid DNA, and critical raw material manufacturing for vaccine and gene therapy applications.

 
 
 
 
 
 
Asymchem CRO/CDMO Small Molecule & Biologics
 

Asymchem is a leading global contract development and manufacturing organization focused on developing practical and sustainable processes for both clinical phase and commercial scale projects in pharmaceutical & biopharmaceutical industries, with the inspections of NMPA, USFDA and other global regulatory authorities.

 
 
 
 
 
 
Sterile Formulation And Fill/Finish For Early-Phase Clinical Trials Of Gene Therapy And Biological Products
 

Ascendia’s team of scientists have decades of combined experience in sterile supplies for clinical trials, making them expert at solving the most difficult formulation challenges. In short, we consistently make the challenge task in biological delivery possible.

 
 
 
 
 
 
High-Throughput Preformulation Development Platform For Biologics
 

A high-throughput formulation development for sample preparation and sample analysis enabled a simple and less labor-intensive screening of a broad range of conditions in considerably less time.

 
 
 
 
 
 
Innovative Drug-Eluting Implants
 

Vitaldose EVA is an enabling technology that formulators can leverage to create effective implants for long-acting controlled release therapeutics.

 
 
 
 
 
 
Recombinant Protein CDMO Services
 

Grifols is your biologics CDMO partner with expertise in process development to GMP manufacturing.

 
 
 
 
 
 
Cytovance Biologics Overview
 

Cytovance Biologics' mission is to partner with clients to provide integral pathways in converting novel API discoveries into future lifesaving therapies and diagnostics. At Cytovance, we provide unparalleled support to biopharmaceutical companies to move candidate molecules from the bench through commercialization.

 
 
 
 
 
 
Virtual Tour: Center Of Excellence For Development Services
 

Our development laboratories support Drug Substance, Analytical and Drug Product development for recombinant protein from microbial and cell culture systems, viral development (recombinant, live and attenuated) ranging from small scale to 200 L scale.

 
 
 
 
 
 
Parenteral Manufacturing Contract Manufacturing & Services
 

Jubilant HollisterStier offers sterile and non-sterile manufacturing services for Phase II through Commercial liquid and lyophilized products. In addition, the Montreal facility offers a wide array of non-sterile manufacturing services for ointments, creams, gels and liquid products. Our flexible filling lines support packaging into bottles, tubes and pumps.

 
 
 
 
 
 
Highly Potent APIs Are Becoming More Potent And Complex
 

Dr. Andreas Meudt, the global head of Exclusive Synthesis for Evonik, shares his thoughts on key growth trends for HPAPIs and why more pharma companies are outsourcing their production to contract specialists.

 
 
 
 
 
 
CDMO R&D Innovation & Proprietary Platforms Improve Speed To Market And Quality For Protein Biologics
 

Through the work of its research and development scientists, AGC Biologics is creating innovations and offering the latest technology for early and late stage clients, helping them focus on increasing mass, increased speed to market, and overall process intensification.

 
 
 
 
 
 
Better Solutions For Your Drug Product: From Development Through Commercialization
 

With world-class facilities, the state-of-the-art equipment and some of the industry’s most talented people, you can feel confident that your drug product is in safe hands. Learning from decades in the CDMO sector, INCOG has been purpose-built to provide better solutions for the global injectable drug product sector.